RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding RxSight, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 45 | 1 | 49 | +5 |
| Shares | 8.75M | 2.07K | 9.31M | +554.6K (+6.3%) |
| Value | $108.3M | $26.0K | $131.0M | +$22.7M (+21.0%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held RxSight, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 176,270 | $2.48M | 0.61% |
| Parkman Healthcare Partners LLC | 115,000 | $1.62M | 0.60% |
| EAM Global Investors LLC | 99,317 | $1.40M | 0.34% |
| Russell Investments Group, Ltd. | 54,246 | $762.0K | 0.00% |
| IHT Wealth Management, LLC | 41,050 | $578.0K | 0.05% |
| Citadel Advisors LLC | 29,988 | $422.0K | 0.00% |
| Alliancebernstein L.P. | 17,194 | $242.0K | 0.00% |
| Saturna Capital CORP | 14,400 | $203.0K | 0.00% |
| Mountain Capital Investment Advisors, Inc | 12,100 | $174.0K | 0.09% |
| MetLife Investment Management | 12,110 | $170.5K | 0.00% |
| Metropolitan Life Insurance Co | 1,405 | $19.8K | 0.00% |
| Credit Suisse AG | 19 | $0 | 0.00% |
Sold out (7)
Institutions that held RxSight, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Boston Private Wealth LLC | 20,303 | $251.0K |
| Point72 Asset Management, L.P. | 17,500 | $217.0K |
| Allspring Global Investments Holdings, LLC | 17,056 | $211.0K |
| Susquehanna International Group, LLP | 10,869 | $135.0K |
| UBS Group AG | 3,888 | $48.0K |
| STRS Ohio | 1,900 | $23.0K |
| Northwestern Mutual Wealth Management Co | 400 | $5.00K |
Not filed for Q2 2022 yet (1)
Institutions that held RxSight, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,072 | $26.0K |